Fetterman appealed to President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. personally.

President Donald Trump has signed an Executive Order aimed at lowering drug prices and reducing Medicare costs.

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

In November last year, the Biden administration proposed a new rule that would allow drugs like Wegovy and Zepbound to be ...

The Centers for Medicare & Medicaid Services will not cover drugs when exclusively used for weight loss, like Ozempic or ...

The proposal would have enabled more Americans to afford new medications in the GLP-1 class that have been shown to reduce ...

President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...